¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"transverse mutation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • genetic mutation
    À¯Àüµ¹¿¬º¯ÀÌ
  • genomic mutation
    À¯Àüüµ¹¿¬º¯ÀÌ
  • induced mutation
    À¯¹ßµ¹¿¬º¯ÀÌ
  • loss-of-function mutation
    ±â´É¼Ò½Çµ¹¿¬º¯ÀÌ
  • missense mutation
    °ú¿Àµ¹¿¬º¯ÀÌ, ¹Ì½º¼¾½ºµ¹¿¬º¯ÀÌ
  • mutation
    µ¹¿¬º¯ÀÌ
  • mutation genetics
    º¯ÀÌÀ¯ÀüÇÐ
  • mutation rate
    µ¹¿¬º¯ÀÌÀ²
  • natural mutation
    ÀÚ¿¬µ¹¿¬º¯ÀÌ
  • nonsense mutation
    ¹«Àǹ̵¹¿¬º¯ÀÌ, ³Í¼¾½ºµ¹¿¬º¯ÀÌ
  • plaque morphology mutation
    ÆÇÇüŵ¹¿¬º¯ÀÌ, ÇöóÅ©Çüŵ¹¿¬º¯ÀÌ
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • polar mutation
    ±Ø¼ºµ¹¿¬º¯ÀÌ
  • population mutation
    Áý´Üµ¹¿¬º¯ÀÌ
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • transverse myelopathy
    °¡·Î¹æÇâô¼öº´Áõ
  • transverse plane
    °¡·Î¸é
  • transverse presentation
    (¢¡transverse lie) ȾÅÂÀ§, °¡·ÎÅÂÀ§
  • transverse process
    °¡·Îµ¹±â
  • transverse relaxation
    °¡·ÎÃàÇ®¸², ȾÃàÀÌ¿Ï
  • transverse scan
    °¡·Î½ºÄµ
  • transverse section
    °¡·Î´Ü¸é
  • transverse septum
    °¡·ÎÁß°Ý
  • transverse sinus
    °¡·ÎÁ¤¸Æ±¼, ½ÉÀ帷°¡·Î±¼
  • transverse
    °¡·Î-, Ⱦ-
  • transverse tubule
    °¡·Î¼¼°ü
  • back mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • chromosomal mutation
    ¿°»öüº¯ÀÌ, ¿°»öüµ¹¿¬º¯ÀÌ
  • cold-sensitive mutation
    Àú¿Â¹Î°¨µ¹¿¬º¯ÀÌ
  • conditional mutation
    Á¶°Çµ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population mutation
    Áý´Ü±ºµ¹¿¬º¯ÀÌ(¡­ÔÍæÔܨì¶).
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ(æëàõÔÍæÔܨì¶).
  • recessive mutation
    ¿­¼ºµ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gene mutation
    À¯ÀüÀÚ(µ¹¿¬)º¯ÀÌ
  • genetic mutation
    À¯ÀüÀû µ¹¿¬º¯ÀÌ
  • genomic mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ
  • host range mutation
    ¼÷ÁÖ¿ªº¯ÀÌ
  • induced mutation
    À¯¹ß¼º µ¹¿¬º¯ÀÌ.
  • induced mutation
    À¯¹ßµ¹¿¬º¯ÀÌ
  • lethal mutation
    Ä¡»çµ¹¿¬º¯ÀÌ(¡­ÔÍæ×ܨì¶).
  • lethal mutation
    Ä¡»ç µ¹¿¬º¯ÀÌ
  • loss mutation
    »ó½Çµ¹¿¬º¯ÀÌ(ßÃã÷ÔÍæÔܨì¶).
  • missense mutation
    °ú¿Àµ¹¿¬º¯ÀÌ(Φè¦ÔÍæÔܨì¶).
  • multiple allelic mutation
    º¹´ë¸³ÇüÁúº¯ÀÌ(ÜÜÓßí¡û¡òõܨì¶).
  • mutation
    (µ¹¿¬)º¯ÀÌ(ÔÍæÔܨì¶)
  • mutation detection
    (µ¹¿¬)º¯À̰ËÃâ
  • mutation disturbance
    º¯¼ºÀå¾Ö(ܨàõî¡äô).
  • mutation genetics
    º¯ÀÌÀ¯ÀüÇÐ(ܨì¶ë¶îîùÊ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Transverse occipital sulcus
    °¡·ÎµÚÅë¼ö°í¶û
    [¿¾ ¿ë¾î] ȾÈĵα¸
  • Transverse arytenoid m.
    °¡·Î¸ð»Ô±Ù
    [¿¾ ¿ë¾î] ȾÇÇ¿­±Ù
  • Transverse cervical artery
    °¡·Î¸ñµ¿¸Æ
    [¿¾ ¿ë¾î] °æÈ¾µ¿¸Æ
  • Transverse nerve of neck
    °¡·Î¸ñ½Å°æ
    [¿¾ ¿ë¾î] °æÈ¾½Å°æ
  • Transverse cervical veins
    °¡·Î¸ñÁ¤¸Æ
    [¿¾ ¿ë¾î] °æÈ¾Á¤¸Æ
  • Transverse tarsal joint
    °¡·Î¹ß¸ñ»À°üÀý
    [¿¾ ¿ë¾î] ȾÁ·±Ù°üÀý
  • Transverse vesical fold
    °¡·Î¹æ±¤ÁÖ¸§
    [¿¾ ¿ë¾î] Ⱦ¹æ±¤ÁÖ¸§
  • Transverse part
    °¡·ÎºÎºÐ
    [¿¾ ¿ë¾î] ȾºÎ
  • Transverse portion
    °¡·ÎºÎºÐ
    [¿¾ ¿ë¾î] ȾºÎ
  • Transverse line
    °¡·Î¼±
    [¿¾ ¿ë¾î] Ⱦ¼±
  • Transverse ductules
    °¡·Î¼¼°ü
    [¿¾ ¿ë¾î] Ⱦ¼Ò°ü
  • Transverse tubule
    °¡·Î¼¼°ü
    [¿¾ ¿ë¾î] Ⱦ¼Ò°ü
  • Transverse facial artery
    °¡·Î¾ó±¼µ¿¸Æ
    [¿¾ ¿ë¾î] ¾È¸éȾµ¿¸Æ
  • Transverse facial vein
    °¡·Î¾ó±¼µ¿¸Æ
    [¿¾ ¿ë¾î] ¾È¸éȾÁ¤¸Æ
  • Transverse palatine suture
    °¡·ÎÀÔõÀåºÀÇÕ
    [¿¾ ¿ë¾î] Ⱦ±¸°³ºÀÇÕ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • isocoding mutation
    ¾ÆÀ̼ÒÄÚµå º¯ÀÌ(ܨì¶)
  • Jimpy mutation
    ÁüÇÇ º¯ÀÌ(ܨì¶)
  • lethal mutation
    Ä¡»çº¯ÀÌ(öÈÞÝܨì¶)
  • lethal mutation model
    Ä¡»çº¯ÀÌ(öÈÞÝܨì¶)¸ðµ¨
  • missense mutation
    ¿ÀÀκ¯ÀÌ(è¦ìãܨì¶)
  • mutation
    º¯ÀÌ(ܨì¶)
  • mutation distance
    º¯ÀÌ(ܨì¶)°Å¸®
  • mutation frequency
    º¯À̺óµµ(ܨì¶ÞºÓø)
  • mutation index
    º¯ÀÌÁö¼ö(ܨì¶ò¦â¦)
  • mutation rate
    º¯ÀÌÀ²(ܨì¶ëÒ)
  • mutation stabilization
    º¯À̾ÈÁ¤È­(ܨì¶äÌïÒûù)
  • mutation theory
    º¯ÀÌ·Ð(ܨì¶Öå)
  • neutral mutation
    Á߸³º¯ÀÌ(ñ騡܍ì¶)
  • nonsense mutation
    ³Í¼¾½º º¯ÀÌ(ܨì¶)
  • ochre mutation
    ¿À¿ìÄ¿º¯ÀÌ(ܨì¶)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • transverse section
    Ⱦ´Ü¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
ROT Right Occipito-Transverse
ACTA American Cardiology Technologists Association; automatic computerized transverse axial [scanning]
AIM Abridged Index Medicus; acute transverse myelopathy; area of interest magnification; artificial inte...
ATM abnormal tubular myelin; acute transverse myelopathy; asynchronous transfer mode; atmosphere
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MCR mutation cluster region
M(f) mutation frequency
Tfm testicular feminization mutation
ATM Acute transverse myelitis
ATM Acute transverse myelopathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mutation
    µ¹¿¬º¯ÀÌ
    1. ÇüÅÂ, ¼º°Ý ȤÀº ¾î¶² ´Ù¸¥ Ư¡¿¡ »ý±ä º¯È­. 2. À¯ÀüÇп¡¼­´Â À¯Àü ¹°Áú¿¡ »ý±ä º¸ÅëÀº ÇϳªÀÇ À¯ÀüÀÚ¿¡ »ý±ä À¯ÀüÀÌ µÇ´Â ¿µ±¸ÀûÀÎ º¯È­. ¶ÇÇÑ °³Ã¼¿¡¼­ ³ªÅ¸³ª´Â º¯È­. ¶ÇÇÑ °íÀü À¯ÀüÇп¡¼­´Â º¯Á¾
  • mutation disturbance
    º¯¼º Àå¾Ö
  • mutation rate
    º¯ÀÌÀ², µ¹¿¬º¯ÀÌÀ²
  • ochre mutation
    ¿À¿ìÄ¿ µ¹¿¬º¯ÀÌ
  • reading framework mutation
    ÆÇµ¶ °ñ°Ý ±¸Á¶ À̵¿ µ¹¿¬º¯ÀÌ
  • reverse mutation
    ȯ¿ø µ¹¿¬ º¯ÀÌ
  • silent mutation
    ¹«ÁõÈÄ µ¹¿¬º¯ÀÌ
  • somatic mutation
    ü ¼¼Æ÷ µ¹¿¬º¯ÀÌ
  • suppressor mutation
    ¾ïÁ¦ µ¹¿¬º¯ÀÌ
  • temperature-sensitive mutation
    ¿Âµµ ¹Î°¨ µ¹¿¬º¯ÀÌ
  • transverse
    °¡·ÎÀÇ, ȾÀÇ
    ºÎºÐÀÇ ÀåÃà¿¡ ´ëÇØ Á÷°¢À¸·Î À§Ä¡ÇÑ.
  • transverse azygos vein
    °¡·Î ȦÁ¤¸Æ
  • transverse cervical vein
    °¡·Î¸ñ Á¤¸Æ
  • transverse diameter
    °¡·Î Á÷°æ, Ⱦ°æ
  • transverse fracture
    Ⱦ°ñÀý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
mutation rate The frequency with which a particular mutation appears in a population or the frequency with which any mutation appears in the whole genome of a population. Normally the context makes the precise use clear.
See: fluctuation analysis.
(18 Nov 1997)
private mutation A rare mutation found usually only in a single family or a small population. It is like a privately printed book.
(12 Dec 1998)
hereditary mutation A gene change that occurs in a germ cell (an egg or sperm) to become incorporated in every cell in the body. Hereditary mutations (also called germline mutations) play a role in cancer as, for example, the eye tumour retinoblastoma and wilms' tumour of the kidney.
(12 Dec 1998)
homeotic mutation <embryology, genetics> A mutation that causes an organism to develop a homologous body part or structure in place of the part or structure that should normally be there (for example, developing a hand in place of a foot).
(09 Oct 1997)
silent mutation Mutations that have no effect on phenotype because they do not affect the activity of the product of the gene, usually because of codon ambiguity.
(18 Nov 1997)
site specific mutation An alteration of the structure of a gene at a specific sequence, usually referring to experimentally produced changes in gene sequence.
(05 Mar 2000)
somatic mutation Mutation that occurs in the somatic tissues of an organism and that will not, therefore, be heritable, since it is not present in the germ line. Some neoplasia is due to somatic mutation, a more conspicuous example is the reversion of some branches of variegated shrubs to the wild type (completely green) phenotype. Somatic mutation is probably also important in generating diversity in V gene regions of immunoglobulins.
(18 Nov 1997)
somatic mutation theory of cancer That cancer is caused by a mutation or mutations in the body cells (as opposed to germ cells), especially nonlethal mutations associated with increased proliferation of the mutant cells.
(05 Mar 2000)
spontaneous mutation A mutation which occurs by itself without first being affected by a mutagen, for example during the process of DNA replication. Spontaneous mutations arise at a remarkably constant rate. The rate that spontaneous mutations arise has been used as an evolutionary clock to estimate how closely related two (or more) separate species are to each other.
(09 Oct 1997)
natural mutation A mutation which occurs by itself without first being affected by a mutagen, for example during the process of DNA replication. Spontaneous mutations arise at a remarkably constant rate. The rate that spontaneous mutations arise has been used as an evolutionary clock to estimate how closely related two (or more) separate species are to each other.
(09 Oct 1997)
neutral mutation A mutation that has no selective advantage or disadvantage. Considerable controversy surrounds the question of whether such mutations can exist.
(18 Nov 1997)
new mutation Redundant term for a heritable trait present in the offspring but in neither parent, i.e., not a pre-existing mutant form inherited.
(05 Mar 2000)
substitution mutation A mutation caused by a nucleotide base being replaced by a different one.
(09 Oct 1997)
nonsense mutation <molecular biology> A mutation that causes a polypeptide chain to be ended prematurely.
(13 Nov 1997)
null mutation Change in a gene that leads to nothing, for example to no enzyme or to a nonfunctioning enzyme.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á